# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Primary Lateral Sclerosis
- **MONDO ID:**  (if available)
- **Category:** Complex

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Primary Lateral Sclerosis**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** perplexity
**Generated:** 2026-02-01T09:36:43.974641

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC10816328/
2. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2023.1189470/full
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC7564998/
4. https://www.physio-pedia.com/Primary_Lateral_Sclerosis
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC10345048/
6. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2019.01310/full
7. https://medicalxpress.com/news/2020-05-mechanism-upper-motor-degeneration-revealed.html
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC4404432/
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC8016556/
10. https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2025.1671419/full
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC2364715/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC7683149/
13. https://pubmed.ncbi.nlm.nih.gov/33602010/
14. https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0009805
15. https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2015.00041/full
16. https://www.ncbi.nlm.nih.gov/books/NBK609096/
17. https://www.ncbi.nlm.nih.gov/books/NBK1107/
18. https://pmc.ncbi.nlm.nih.gov/articles/PMC12028049/
19. https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2022.892518/full
20. https://jamanetwork.com/journals/jamaneurology/fullarticle/796817
21. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.01005/full
22. https://pmc.ncbi.nlm.nih.gov/articles/PMC4251436/
23. https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2023.1172197/full
24. https://pmc.ncbi.nlm.nih.gov/articles/PMC2842587/
25. https://pubmed.ncbi.nlm.nih.gov/31036551/
26. https://pmc.ncbi.nlm.nih.gov/articles/PMC6531423/
27. https://pubmed.ncbi.nlm.nih.gov/38891774/
28. https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2022.1000183/full
29. https://pmc.ncbi.nlm.nih.gov/articles/PMC3986607/
30. https://pmc.ncbi.nlm.nih.gov/articles/PMC4621950/
31. https://www.ncbi.nlm.nih.gov/books/NBK268647/
32. https://academic.oup.com/brain/article/140/6/1611/3739751
33. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2015.00448/full
34. https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2017.00263/full
35. https://pmc.ncbi.nlm.nih.gov/articles/PMC5758557/
36. https://pmc.ncbi.nlm.nih.gov/articles/PMC3434688/
37. https://pmc.ncbi.nlm.nih.gov/articles/PMC6170747/
38. https://pmc.ncbi.nlm.nih.gov/articles/PMC9230865/
39. https://my.clevelandclinic.org/health/diseases/17986-primary-lateral-sclerosis
40. https://pmc.ncbi.nlm.nih.gov/articles/PMC6617949/
41. https://www.neurology.org/doi/10.1212/WNL.0000000000000090
42. https://pmc.ncbi.nlm.nih.gov/articles/PMC7012787/
43. https://academic.oup.com/braincomms/article/6/5/fcae350/7811348
44. https://pmc.ncbi.nlm.nih.gov/articles/PMC9294906/
45. https://www.theaftd.org/what-is-ftd/ftd-and-als-ftd-als/
46. https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2023.1047897/full
47. https://pmc.ncbi.nlm.nih.gov/articles/PMC5800968/
48. https://pmc.ncbi.nlm.nih.gov/articles/PMC3187864/
49. https://pmc.ncbi.nlm.nih.gov/articles/PMC9248913/
50. https://febs.onlinelibrary.wiley.com/doi/10.1002/1873-3468.12646
51. https://academic.oup.com/brain/article/140/4/887/3052232
52. https://pmc.ncbi.nlm.nih.gov/articles/PMC7225320/
53. https://pmc.ncbi.nlm.nih.gov/articles/PMC6349704/
54. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.924734/full
55. https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2020.00078/full
56. https://pmc.ncbi.nlm.nih.gov/articles/PMC6209630/